Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vronchiolitis and its treatment].

Georges de Bilderling1

  • 1Service de pédiatrie Cliniques UCL Mont-Godinne. georges.debilderling@pedi.ucl.ac.be

Journal De Pharmacie De Belgique
|May 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Streptococcus pneumoniae clinical isolate highly resistant to fluoroquinolones in a child.

The Pediatric infectious disease journal·2006
Same author

Gas cooking and smoking habits and the risk of childhood and adolescent wheeze.

American journal of epidemiology·2005
Same author

Is procalcitonin a good marker of renal lesion in febrile urinary tract infection?

European journal of pediatrics·2005
Same author

Exercise-induced respiratory symptoms are poor predictors of bronchoconstriction.

Pediatric pulmonology·2005
Same author

Successful use of intralesional and intravenous cidofovir in association with indole-3-carbinol in an 8-year-old girl with pulmonary papillomatosis.

Journal of medical virology·2004
Same author

Pneumococcal psoas pyomyositis associated with complement deficiency.

The Pediatric infectious disease journal·2004

Bronchiolitis, a common infant illness caused by RSV, leads to high healthcare costs due to frequent hospitalizations and unproven treatments. Evidence-based guidelines can lower costs but don't improve parental satisfaction or care quality.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Respiratory Medicine

Context:

  • Bronchiolitis is the most frequent lower respiratory tract infection in infants.
  • Respiratory Syncytial Virus (RSV) is the primary causative agent.
  • High hospitalization rates and treatments with unproven efficacy contribute to significant public health costs.

Purpose:

  • To evaluate the impact of evidence-based guidelines on bronchiolitis management.
  • To assess the effectiveness of Palivizumab as a preventive measure.
  • To explore interventions for post-bronchiolitis bronchial hyperreactivity.

Summary:

  • Evidence-based guidelines can reduce healthcare costs associated with bronchiolitis but do not enhance parental satisfaction or care quality.
  • Palivizumab is a preventive medication with specific indications for certain infants.

Related Experiment Videos

  • Post-bronchiolitis bronchial hyperreactivity is observed, especially after hospitalization, with no proven effective treatments currently available.

    • Impact:

    • Implementation of guidelines can optimize resource allocation in pediatric respiratory care.
    • Understanding Palivizumab's role aids in targeted preventive strategies.
    • Further research is needed to identify effective treatments for post-bronchiolitis bronchial hyperreactivity to improve long-term infant respiratory health.